While Inspire Medical Systems Inc has underperformed by -1.75%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, INSP fell by -14.96%, with highs and lows ranging from $330.00 to $123.27, whereas the simple moving average jumped by 10.37% in the last 200 days.
On April 19, 2024, RBC Capital Mkts started tracking Inspire Medical Systems Inc (NYSE: INSP) recommending Outperform. A report published by Morgan Stanley on March 19, 2024, Initiated its previous ‘Overweight’ rating for INSP. KeyBanc Capital Markets also rated INSP shares as ‘Overweight’, setting a target price of $278 on the company’s shares in an initiating report dated February 06, 2024. Jefferies Initiated an Buy rating on January 19, 2024, and assigned a price target of $245. Stifel January 02, 2024d its ‘Buy’ rating to ‘Hold’ for INSP, as published in its report on January 02, 2024. Wells Fargo’s report from December 13, 2023 suggests a price prediction of $187 for INSP shares, giving the stock a ‘Equal Weight’ rating. Robert W. Baird also rated the stock as ‘Outperform’.
Analysis of Inspire Medical Systems Inc (INSP)
Further, the quarter-over-quarter increase in sales is 39.60%, showing a positive trend in the upcoming months.
One of the most important indicators of Inspire Medical Systems Inc’s future performance is equity, which can be evaluated using several well-rounded types of analysis and research techniques. The goal here is to ensure that your current return on equity of -3.96% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 7.17, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can also provide valuable insight into volatility, and INSP is recording 510.11K average volume. On a monthly basis, the volatility of the stock is set at 5.20%, whereas on a weekly basis, it is put at 6.03%, with a gain of 0.93% over the past seven days. Furthermore, long-term investors anticipate a median target price of $255.32, showing growth from the present price of $225.22, which can serve as yet another indication of whether INSP is worth investing in or should be passed over.
How Do You Analyze Inspire Medical Systems Inc Shares?
Along with the fundamentals, it is also important to consider how many employees own shares of the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 2.09%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 102.54% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
INSP shares are owned by institutional investors to the tune of 102.54% at present.
